Skip to main content
. 2020 Apr 16;31(6):1335–1347. doi: 10.1681/ASN.2019121285

Figure 4.

Figure 4.

Urine CD163 levels during treatment of lupus nephritis are associated with response to therapy. Course of uCD163 in response to therapy in complete (CR), partial (PR), and nonresponders (NR) in (A) the Mexican cohort and (B) the OSS cohort. The graph shows the estimated means and their 95% confidence intervals obtained from the linear mixed model analysis. The gray area identifies the cutoff of uCD163=370 ng/mmol.